460 related articles for article (PubMed ID: 21402116)
1. Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors.
Qi T; Ly K; Poyner DR; Christopoulos G; Sexton PM; Hay DL
Peptides; 2011 May; 32(5):1060-7. PubMed ID: 21402116
[TBL] [Abstract][Full Text] [Related]
2. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
[TBL] [Abstract][Full Text] [Related]
3. Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3.
Robinson SD; Aitken JF; Bailey RJ; Poyner DR; Hay DL
J Pharmacol Exp Ther; 2009 Nov; 331(2):513-21. PubMed ID: 19644039
[TBL] [Abstract][Full Text] [Related]
4. Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.
Watkins HA; Walker CS; Ly KN; Bailey RJ; Barwell J; Poyner DR; Hay DL
Br J Pharmacol; 2014 Feb; 171(3):772-88. PubMed ID: 24199627
[TBL] [Abstract][Full Text] [Related]
5. The role of glutamic acid 73 in adrenomedullin interactions with rodent AM2 receptors.
Halim A; Hay DL
Peptides; 2012 Jul; 36(1):137-41. PubMed ID: 22546239
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.
Pawlak JB; Wetzel-Strong SE; Dunn MK; Caron KM
Peptides; 2017 Feb; 88():1-7. PubMed ID: 27940069
[TBL] [Abstract][Full Text] [Related]
7. Probing the Mechanism of Receptor Activity-Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Peptide Antagonists.
Booe JM; Warner ML; Roehrkasse AM; Hay DL; Pioszak AA
Mol Pharmacol; 2018 Apr; 93(4):355-367. PubMed ID: 29363552
[TBL] [Abstract][Full Text] [Related]
8. Potentiated response to adrenomedullin in myocardia and aortas in spontaneously hypertensive rat.
Pan ChS; Jiang W; Wu ShY; Zhao J; Pang YZ; Tang ChS; Qi YF
Basic Res Cardiol; 2006 May; 101(3):193-203. PubMed ID: 16450076
[TBL] [Abstract][Full Text] [Related]
9. Aspartate(69) of the calcitonin-like receptor is required for its functional expression together with receptor-activity-modifying proteins 1 and -2.
Ittner LM; Luessi F; Koller D; Born W; Fischer JA; Muff R
Biochem Biophys Res Commun; 2004 Jul; 319(4):1203-9. PubMed ID: 15194494
[TBL] [Abstract][Full Text] [Related]
10. Progesterone upregulates calcitonin gene-related peptide and adrenomedullin receptor components and cyclic adenosine 3'5'-monophosphate generation in Eker rat uterine smooth muscle cell line.
Thota C; Yallampalli C
Biol Reprod; 2005 Feb; 72(2):416-22. PubMed ID: 15469997
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the single transmembrane domain of human receptor activity-modifying protein 3 in adrenomedullin receptor internalization.
Kuwasako K; Kitamura K; Nagata S; Nozaki N; Kato J
Biochem Biophys Res Commun; 2012 Apr; 420(3):582-7. PubMed ID: 22445753
[TBL] [Abstract][Full Text] [Related]
12. Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments.
Thota C; Gangula PR; Dong YL; Yallampalli C
Biol Reprod; 2003 Oct; 69(4):1432-7. PubMed ID: 12801991
[TBL] [Abstract][Full Text] [Related]
13. Shared and separate functions of the RAMP-based adrenomedullin receptors.
Kuwasako K; Kitamura K; Nagata S; Hikosaka T; Takei Y; Kato J
Peptides; 2011 Jul; 32(7):1540-50. PubMed ID: 21645567
[TBL] [Abstract][Full Text] [Related]
14. Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat.
Edvinsson L; Eftekhari S; Salvatore CA; Warfvinge K
Mol Cell Neurosci; 2011 Jan; 46(1):333-9. PubMed ID: 21040789
[TBL] [Abstract][Full Text] [Related]
15. Structure-function analyses reveal a triple β-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design.
Roehrkasse AM; Booe JM; Lee SM; Warner ML; Pioszak AA
J Biol Chem; 2018 Oct; 293(41):15840-15854. PubMed ID: 30139742
[TBL] [Abstract][Full Text] [Related]
16. A critical role for the short intracellular C terminus in receptor activity-modifying protein function.
Udawela M; Christopoulos G; Morfis M; Christopoulos A; Ye S; Tilakaratne N; Sexton PM
Mol Pharmacol; 2006 Nov; 70(5):1750-60. PubMed ID: 16912219
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological and kinetic characterization of adrenomedullin 1 and calcitonin gene-related peptide 1 receptor reporter cell lines.
Wunder F; Rebmann A; Geerts A; Kalthof B
Mol Pharmacol; 2008 Apr; 73(4):1235-43. PubMed ID: 18174292
[TBL] [Abstract][Full Text] [Related]
18. Adrenomedullin and calcitonin gene-related peptide receptors in endocrine-related cancers: opportunities and challenges.
Hay DL; Walker CS; Poyner DR
Endocr Relat Cancer; 2011 Feb; 18(1):C1-14. PubMed ID: 21051558
[TBL] [Abstract][Full Text] [Related]
19. Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors--the role of receptor activity modifying protein 1.
Hay DL; Christopoulos G; Christopoulos A; Sexton PM
Mol Pharmacol; 2006 Dec; 70(6):1984-91. PubMed ID: 16959943
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of two human receptor activity-modifying protein 3 variants.
Bailey RJ; Bradley JW; Poyner DR; Rathbone DL; Hay DL
Peptides; 2010 Apr; 31(4):579-84. PubMed ID: 20034525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
